Giuseppe Gigli Selected Research

Giuseppe Gigli Research Topics

Disease

14	Neoplasms (Cancer) 08/2023 - 11/2010
3	Breast Neoplasms (Breast Cancer) 04/2022 - 10/2017
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2015 - 04/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2023 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2022 - 01/2021
1	Acidosis 08/2023
1	Hypoxia (Hypoxemia) 08/2023
1	Colorectal Neoplasms (Colorectal Cancer) 06/2023
1	Sepsis (Septicemia) 05/2023
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 02/2023
1	Muscular Dystrophies (Muscular Dystrophy) 02/2023
1	Muscular Atrophy (Muscle Atrophy) 11/2022
1	Neuroblastoma 04/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022
1	Hyperthermia 02/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Motor Neuron Disease (Primary Lateral Sclerosis) 11/2021
1	Melanoma (Melanoma, Malignant) 10/2021
1	Non-alcoholic Fatty Liver Disease 05/2021
1	Liver Diseases (Liver Disease) 05/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Glioma (Gliomas) 01/2021
1	Catalepsy 12/2019
1	Circulating Neoplastic Cells 01/2018
1	Inflammation (Inflammations) 10/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Leukemia 04/2010

Drug/Important Bio-Agent (IBA)

3	HydrogelsIBA 06/2023 - 11/2021
3	Silicon Dioxide (Silica)FDA LinkGeneric 04/2022 - 11/2010
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 02/2015
3	Imatinib Mesylate (Gleevec)FDA Link 02/2015 - 04/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023
1	Tumor Biomarkers (Tumor Markers)IBA 08/2023
1	Protons (Proton)IBA 06/2023
1	CalciumIBA 03/2023
1	givinostatIBA 02/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2023
1	Gemcitabine FDA Link 01/2023
1	ThiophenesIBA 04/2022
1	SolutionsIBA 04/2022
1	alpha-terthienyl (terthiophene)IBA 04/2022
1	OxidesIBA 04/2022
1	Temozolomide (Temodar)FDA LinkGeneric 03/2022
1	ferric oxide (iron oxide)IBA 02/2022
1	polycaprolactoneIBA 02/2022
1	ChitosanIBA 11/2021
1	ElementsIBA 11/2021
1	PectinsIBA 11/2021
1	Polyvinyl AlcoholIBA 10/2021
1	Gum Arabic (Acacia, Gum)FDA Link 10/2021
1	GoldIBA 10/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 09/2021
1	2- (2- cresyl)- 4H- 1- 3- 2- benzodioxaphosphorin- 2- oxideIBA 09/2021
1	polyethylene glycol polyethyleneimine nanogelIBA 05/2021
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2021
1	Bentonite (Montmorillonite)IBA 01/2021
1	ClayIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 09/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	Dronabinol (THC)FDA LinkGeneric 12/2019
1	CannabinoidsIBA 12/2019
1	PlatinumIBA 12/2019
1	AntibodiesIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 10/2017
1	PolymersIBA 10/2017
1	Biocompatible Materials (Biomaterials)IBA 10/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2017
1	caprolactoneIBA 10/2017
1	GlypicansIBA 01/2017
1	Oncogene Proteins (Oncogene Protein)IBA 07/2014
1	Tyrosine Kinase InhibitorsIBA 07/2014
1	Contrast MediaIBA 11/2010
1	Capsules (Microcapsules)IBA 04/2010
1	PolyelectrolytesIBA 04/2010

Therapy/Procedure

9	Therapeutics 06/2023 - 04/2010
4	Precision Medicine 06/2023 - 01/2018
3	Drug Therapy (Chemotherapy) 03/2022 - 10/2017
1	Transplantation 05/2023
1	Denervation 11/2022
1	Nutritional Support (Artificial Feeding) 11/2022
1	Radiotherapy 03/2022
1	Drug Administration Routes 05/2021
1	Quantum Dots (Quantum Dot) 01/2020
1	Analgesia 12/2019
1	Nanospheres 11/2010